531681 — Amerise Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹40.30m
- IN₹41.25m
- 16
- 43
- 36
- 17
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.041 | -1.49 | -3.37 | 5.49 | -1.19 |
Depreciation | |||||
Non-Cash Items | 0 | 0 | 0 | 0 | — |
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -17.8 | 50.4 | -0.574 | -4.88 | -0.132 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -17.8 | 48.9 | -3.94 | 0.614 | -1.32 |
Other Investing Cash Flow Items | 17.7 | -48.9 | 3.89 | -1.5 | 1.25 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 17.7 | -48.9 | 3.89 | -1.5 | 1.25 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 0 | 0 | 0.827 | 0.073 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.139 | 0.067 | -0.058 | -0.064 | 0.007 |